The FDA has approved Mimrylo—also known as rusfertide—a first-in-class peptide treatment for erythrocytosis in adults with …
FDA Approves Rusfertide: A First-of-Its-Kind Peptide for Polycythemia Vera
Leave a Comment
The FDA has approved Mimrylo—also known as rusfertide—a first-in-class peptide treatment for erythrocytosis in adults with …
